That reflects what Health and Human Services Secretary Xavier Becerra says was an overestimate in costs of covering a controversial new Alzheimer’s drug.
WASHINGTON — Medicare recipients will get a premium reduction — but not until next year — reflecting what Health and Human Services Secretary Xavier Becerra said Friday was an overestimate in costs of covering an expensive and controversial new Alzheimer’s drug.
Medicare Part B premiums jumped by $22 a month, to $170.10, for 2022, in part because of the cost of the drug Aduhelm, which was approved despite weak evidence that it could slow the progression of Alzheimer’s.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New 2023 Audi A4 Avant undergoes tests in the Alps | AutocarNext-generation A4 range will be topped by electric and hybrid RS4 duo
Read more »
Preen by Thornton Bregazzi Resort 2023 CollectionPreen by Thornton Bregazzi Resort 2023 collection, runway looks, beauty, models, and reviews.
Read more »
Review: 2023 Acura Integra recaptures glory of days pastFrom Civic Si beginnings, Acura spins a winning reincarnation of its original compact-car classic.
Read more »
Congressional Budget Office says inflation to last into 2023The Congressional Budget Office released an economic outlook Wednesday saying high inflation will persist into next year, likely causing the federal government to pay higher interest rates on its debt.
Read more »
Peter Kay's 2023 tour announcement will be culmination of star's gradual returnPeter Kay's 2023 tour announcement will prove to be a culmination of his gradual return to the spotlight after cancelling all his commitments in 2017 due to personal reasons
Read more »